A Self-Delivery Chimeric Peptide for Photodynamic Therapy Amplified Immunotherapy
A Self-Delivery Chimeric Peptide for Photodynamic Therapy Amplified Immunotherapy
复制标题
用于光动力疗法放大免疫疗法的自传递嵌合肽
DOI:
10.1002/mabi.201800410
复制
发表时间:
2019-04-01
影响因子:
4.6
通讯作者:
Li, Shi-Ying
中科院分区:
文献类型:
--
作者:
Cheng, Hong;Fan, Gui-Ling;Li, Shi-Ying
In this paper, a self-delivery chimeric peptide PpIX-PEG(8)-KVPRNQDWL is designed for photodynamic therapy (PDT) amplified immunotherapy against malignant melanoma. After self-assembly into nanoparticles (designated as PPMA), this self-delivery system shows high drug loading rate, good dispersion, and stability as well as an excellent capability in producing reactive oxygen species (ROS). After cellular uptake, the ROS generated under light irradiation could induce the apoptosis and/or necrosis of tumor cells, which would subsequently stimulate the anti-tumor immune response. On the other hand, the melanoma specific antigen (KVPRNQDWL) peptide could also activate the specific cytotoxic T cells for anti-tumor immunity. Compared to immunotherapy alone, the combined photodynamic immunotherapy exhibits significantly enhanced inhibition of melanoma growth. Both in vitro and in vivo investigations confirm that PDT of PPMA has a positive effect on anti-tumor immune response. This self-delivery system demonstrates a great potential of this PDT amplified immunotherapy strategy for advanced or metastatic tumor treatment.